Trial · NCT00689936
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Active Treatment Phase | STARTED | Lenalidomide and Low-Dose Dexamethasone (Rd) | 535 | |
| Active Treatment Phase | STARTED | Lenalidomide and Dexamethasone Rd18 | 541 | |
| Active Treatment Phase | STARTED | Melphalan + Prednisone + Thalidomide (MPT) | 547 | |
| Active Treatment Phase | Safety Population | Lenalidomide and Low-Dose Dexamethasone (Rd) | 532 | |
| Active Treatment Phase | Safety Population | Lenalidomide and Dexamethasone Rd18 | 540 | |
| Active Treatment Phase | Safety Population | Melphalan + Prednisone + Thalidomide (MPT) | 541 | |
| Active Treatment Phase | Untreated | Lenalidomide and Low-Dose Dexamethasone (Rd) | 3 | |
| Active Treatment Phase | Untreated | Lenalidomide and Dexamethasone Rd18 | 1 | |
| Active Treatment Phase | Untreated | Melphalan + Prednisone + Thalidomide (MPT) | 6 | |
| Active Treatment Phase | COMPLETED | Lenalidomide and Low-Dose Dexamethasone (Rd) | 0 | |
| Active Treatment Phase | COMPLETED | Lenalidomide and Dexamethasone Rd18 | 0 | |
| Active Treatment Phase | COMPLETED | Melphalan + Prednisone + Thalidomide (MPT) | 0 | |
| Active Treatment Phase | NOT COMPLETED | Lenalidomide and Low-Dose Dexamethasone (Rd) | 535 | |
| Active Treatment Phase | NOT COMPLETED | Lenalidomide and Dexamethasone Rd18 | 541 | |
| Active Treatment Phase | NOT COMPLETED | Melphalan + Prednisone + Thalidomide (MPT) | 547 | |
| Progression Free Survival-PFS-Follow-Up | STARTED | Lenalidomide and Low-Dose Dexamethasone (Rd) | 87 | |
| Progression Free Survival-PFS-Follow-Up | STARTED | Lenalidomide and Dexamethasone Rd18 | 300 | |
| Progression Free Survival-PFS-Follow-Up | STARTED | Melphalan + Prednisone + Thalidomide (MPT) | 273 | |
| Progression Free Survival-PFS-Follow-Up | COMPLETED | Lenalidomide and Low-Dose Dexamethasone (Rd) | 87 | |
| Progression Free Survival-PFS-Follow-Up | COMPLETED | Lenalidomide and Dexamethasone Rd18 | 300 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00689936/flow